Skip to main content

Advertisement

SpringerLink
Log in

Cholestasis in a Patient of Multiple Myeloma: A Rare Occurrence of Bortezomib Induced Liver Injury

  • Correspondence
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Vuppalanchi R, Liangpunsakul S, Chalasani N (2007) Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States? Am J Gastroenterol 102:558–562

    Article  PubMed  Google Scholar 

  2. Rahhal FE, Schade RR, Nayak A, Coleman TA (2009) Hepatic failure caused by plasma cell infiltration in multiple Myeloma. World J Gastroenterol 15:2038–2040

    Article  PubMed  PubMed Central  Google Scholar 

  3. Malhotra P, Bhat P, Mahi S, Chauhan S, Rajwanshi A, Varma S (2005) Evolution of hepatosplenic plasmacytoma in a patient with multiple myeloma receiving chemotherapy. Am J Hematol 78:82–83

    Article  PubMed  Google Scholar 

  4. Trojan A, Chasse E, Gay B, Pichert G, Taverna C (2003) Severe hepatic toxicity due to thalidomide in relapsed multiple myeloma. Ann Oncol 14:501–502

    Article  CAS  PubMed  Google Scholar 

  5. Kim Y, Kim KY, Lee SH, Chung YY, Yahng SA, Lee SE, Park G (2012) A case of drug-induced hepatitis due to bortezomib in multiple myeloma. Immune Netw 12:126–128

    Article  PubMed  PubMed Central  Google Scholar 

  6. Rosiñol L, Montoto S, Cibeira MT, Bladé J (2005) Bortezomib-induced severe hepatitis in multiple myeloma: a case report. Arch Intern Med 165:464–465

    Article  PubMed  Google Scholar 

  7. Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ (2014) ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol 109:950–966

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, 4th Floor, Nehru Hospital, PGIMER, Chandigarh, India

    Ankur Jain, Pankaj Malhotra, Vikas Suri & Subhash Varma

  2. Department of Histopathology, PGIMER, Chandigarh, India

    Ashim Das & Suvradeep Mitra

Authors
  1. Ankur Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pankaj Malhotra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vikas Suri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Subhash Varma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ashim Das
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Suvradeep Mitra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pankaj Malhotra.

Ethics declarations

The article complies with the ethical guidelines as per the Helsinki declaration.

Conflict of interest

The authors declare no conflicts of interests.

Consent for Publication

Consent for publication was obtained from the patient prior to the submission of the article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jain, A., Malhotra, P., Suri, V. et al. Cholestasis in a Patient of Multiple Myeloma: A Rare Occurrence of Bortezomib Induced Liver Injury. Indian J Hematol Blood Transfus 32 (Suppl 1), 181–183 (2016). https://doi.org/10.1007/s12288-016-0665-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-016-0665-z

Keywords

Search

Navigation